IR.N Hits 5-Day High Amid Leadership Changes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 21 Nov 25
Source: Coinmarketcap
Shares of Quanterix Corporation (IR.N) reached a 5-day high today, reflecting positive investor sentiment following recent leadership appointments. The company has welcomed Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to its Board of Directors, while William Donnelly has been named Executive Chair. These strategic changes are aimed at bolstering Quanterix's growth initiatives, particularly in expanding its biomarker offerings and launching new diagnostic tools for Alzheimer's disease. The enhanced board composition, with a majority of independent members, is expected to align operational strategies and support the company's ambitious goals in the life sciences sector.
Analyst Views on IR
Wall Street analysts forecast IR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IR is 90.50 USD with a low forecast of 81.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 85.250
Low
81.00
Averages
90.50
High
100.00
Current: 85.250
Low
81.00
Averages
90.50
High
100.00
About IR
Ingersoll Rand Inc. is a provider of mission-critical flow creation and life sciences and industrial solutions. Its Industrial Technologies and Services segment designs, manufactures, markets and services a range of compression and vacuum equipment as well as fluid transfer equipment, and loading systems. Its compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, clean energy, environmental and other applications. The Precision and Science Technologies segment, designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment, single-use powder handling systems, and contract design and production services for silicone, thermoplastic, and specialty components and assemblies for medical devices. It also designs and manufactures plastic product solutions for life science and healthcare technology industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
